SlideShare une entreprise Scribd logo
1  sur  2
Télécharger pour lire hors ligne
Andrew Lloyd & Associates joins forces with Adebiotech
to foster cross-discipline innovation in biotech industries
ALA will help raise Adebiotech’s profile and support the independent think-tank
in its growth
Paris, France, March 2, 2016 – Andrew Lloyd & Associates (ALA), an international
public relations group for companies and organizations working in life sciences and
innovative technologies, and Adebiotech, an independent cross-disciplinary think-tank for
biotechnology in France, today announce that they have signed a partnership agreement
to promote interdisciplinary discussion and innovation in the field of biotechnology. In
particular, this partnership aims to raise awareness of Adebiotech’s activities amongst
specialist audiences interested in developments concerning human and animal health,
the environment, energy, food processing, cosmetics, processes and industrial systems,
amongst others.
Founded in 2006 and boasting 2,000 members and supporters, Adebiotech leads working
groups that result in national scientific conferences in emerging areas with strong societal
implications. The organization’s activities include connecting public and private bodies
with national and regional institutions, and representatives of civil society. The next
event will address the issue of antibiotic resistance (An integrated approach, from the
environment to mankind – webpage in French). Sponsored by the French Ministry of
Social Affairs and Health, the event will play host to all the main players in the field, who
will be addressed by 40 speakers on March 16 and 17 at the Biocitech city complex for
healthcare and biotechnology businesses in Romainville, France.
ALA will support and advise Adebiotech on its public relations activities throughout the
year, with the aim of raising the organization’s profile and increasing the visibility of its
activities and partnerships, as well as its events. In return, ALA will have opportunities to
engage with Adebiotech’s network and its members.
“We have chosen to join forces with Andrew Lloyd & Associates, which has a wealth of
specialist public relations experience, to support the development of Adebiotech’s
reputation and allow us to take part in the cross-disciplinary public debate on
biotechnology. Biotech is pervasive to all sectors and represents a major source of jobs
and opportunities for growth,” said Manuel Gea, chairman of Adebiotech. “In the
immediate future, this strategic partnership with ALA allows us to raise awareness among
key media about our work and conference achievements. It will also have long-term
benefits for the organization and all our members, allowing us to position ourselves as
the leading player at the forefront of the scientific, business and social debates within
biotechnology.”
“We are delighted to have established this agreement with Adebiotech that focuses on
key areas right at the core of our expertise,” said Juliette dos Santos, director at Andrew
Lloyd & Associates. “Since our company was founded in 1987, we have specialized in
innovative technologies and are involved in all the areas that Adebiotech covers at its
conferences, from environment to energy via health care. As such, we are well placed to
support the organization by increasing its visibility with its target audience, both in the
media and via social networks.”
About Adebiotech
With France’s largest cross-disciplinary network in the life sciences, Adebiotech promotes
dialog between industry – SMEs and large corporations – and academia in the field of
biotechnology. Its mandate is diverse:
· Promote and support responsible innovation
· Break down barriers between disciplines and fields of application
· Support existing industrial processes, create new ones and foster their development
· Contribute to the dialog between private and public players
· Eliminate scientific, technological, regulatory and ethical constraints
Adebiotech works across all the fields of application for biotechnology, covering human
and animal health, the environment, energy, food processing, cosmetics, processes and
industrial systems and creating unprecedented synergies that are required for meeting
the challenges of innovation.
Founded in 2006, Adebiotech now has 2,000 members and supporters. It enjoys support
for its work from ministerial and local authority representatives.
http://www.adebiotech.org
About Andrew Lloyd & Associates
Founded in 1987, Andrew Lloyd & Associates (ALA) is an international public relations
consulting group for leading edge companies and organizations involved in emerging
technologies. ALA has offices in the United Kingdom and France with multicultural,
multilingual staff working closely with partner companies throughout Europe and the US.
It is active in technical, business, financial and scientific communications. Specialized in
biotechnology, pharmaceuticals, electronics hardware, IT and photonics, ALA provides
strategic communication and caters to the full range of public relations requirements for
clients ranging from start-ups to major corporations, including institutions, events,
organizations and technology clusters. ALA offers strategic positioning, international
media relations, influencers and analyst contact management, communication audits,
community management, and produces content for marketing collateral.
http://www.ala.com
Media contact and analysts
Andrew Lloyd and Associates
Lise Beltzung – Juliette Dos Santos
lise@ala.com / juliette@ala.com
Tel: +33 1 56 54 07 00
@ALA_Group

Contenu connexe

Similaire à 160302 Partnership Adebiotech ALA_EN final

Similaire à 160302 Partnership Adebiotech ALA_EN final (20)

Guía de empresas de Biotecnología en Chile / Guide Chilean Biotechnology Comp...
Guía de empresas de Biotecnología en Chile / Guide Chilean Biotechnology Comp...Guía de empresas de Biotecnología en Chile / Guide Chilean Biotechnology Comp...
Guía de empresas de Biotecnología en Chile / Guide Chilean Biotechnology Comp...
 
What is MedTech Week 2017
What is MedTech Week 2017What is MedTech Week 2017
What is MedTech Week 2017
 
Health equals wealth: How can the UK and EU work together towards healthy age...
Health equals wealth: How can the UK and EU work together towards healthy age...Health equals wealth: How can the UK and EU work together towards healthy age...
Health equals wealth: How can the UK and EU work together towards healthy age...
 
Health 2.0 San Antonio Vision & Planning
Health 2.0 San Antonio Vision & PlanningHealth 2.0 San Antonio Vision & Planning
Health 2.0 San Antonio Vision & Planning
 
Spain’s Top 10 Companies Booming in Healthcare Sector 2022.pdf
Spain’s Top 10 Companies Booming in Healthcare Sector 2022.pdfSpain’s Top 10 Companies Booming in Healthcare Sector 2022.pdf
Spain’s Top 10 Companies Booming in Healthcare Sector 2022.pdf
 
Biocat presentation
Biocat presentationBiocat presentation
Biocat presentation
 
WORKSHOP 9 DIC 2011 - Agrimi
WORKSHOP 9 DIC 2011 - AgrimiWORKSHOP 9 DIC 2011 - Agrimi
WORKSHOP 9 DIC 2011 - Agrimi
 
GMDVA ACADEMY AND INNOVATION ALLIANCE.pptx
GMDVA ACADEMY AND INNOVATION ALLIANCE.pptxGMDVA ACADEMY AND INNOVATION ALLIANCE.pptx
GMDVA ACADEMY AND INNOVATION ALLIANCE.pptx
 
February meeting - Welcome to 2015
February meeting - Welcome to 2015February meeting - Welcome to 2015
February meeting - Welcome to 2015
 
Waves of Change Forum Biarritz, FR June 7-9 2020
Waves of Change Forum Biarritz, FR June 7-9 2020Waves of Change Forum Biarritz, FR June 7-9 2020
Waves of Change Forum Biarritz, FR June 7-9 2020
 
TCIOceania15 WelfareTech - Towards Industrialisation
TCIOceania15 WelfareTech - Towards IndustrialisationTCIOceania15 WelfareTech - Towards Industrialisation
TCIOceania15 WelfareTech - Towards Industrialisation
 
NiBUCCA Brochure 2021
NiBUCCA Brochure 2021NiBUCCA Brochure 2021
NiBUCCA Brochure 2021
 
Presentation done by Oliver Blin
Presentation done by Oliver BlinPresentation done by Oliver Blin
Presentation done by Oliver Blin
 
Corporate Social Responsibility presentation - BAF
Corporate Social Responsibility presentation - BAFCorporate Social Responsibility presentation - BAF
Corporate Social Responsibility presentation - BAF
 
TSB REPORT 2009
TSB REPORT   2009TSB REPORT   2009
TSB REPORT 2009
 
DIEH_SET_2015_
DIEH_SET_2015_DIEH_SET_2015_
DIEH_SET_2015_
 
New Orleans BioInnovation Center 2016 Annual Report
New Orleans BioInnovation Center 2016 Annual ReportNew Orleans BioInnovation Center 2016 Annual Report
New Orleans BioInnovation Center 2016 Annual Report
 
10 European Startups Shaking the Future of Healthcare 2023V2 1 (1).pdf
10 European Startups Shaking the Future of Healthcare 2023V2 1 (1).pdf10 European Startups Shaking the Future of Healthcare 2023V2 1 (1).pdf
10 European Startups Shaking the Future of Healthcare 2023V2 1 (1).pdf
 
ECH alliance: the global connector: KTN Horizon 2020 event - Andy Bleaden
ECH alliance: the global connector: KTN Horizon 2020 event - Andy BleadenECH alliance: the global connector: KTN Horizon 2020 event - Andy Bleaden
ECH alliance: the global connector: KTN Horizon 2020 event - Andy Bleaden
 
A young doctor guide to Health Innovation Tg Mures Dec 2022.pdf
A young doctor guide to Health Innovation Tg Mures Dec 2022.pdfA young doctor guide to Health Innovation Tg Mures Dec 2022.pdf
A young doctor guide to Health Innovation Tg Mures Dec 2022.pdf
 

Plus de Manuel GEA - Bio-Modeling Systems

Pherecydes-Pharma-bmsystems-spin-off-Phase-I-II-Clinical-Trial-EN-VF-150909
Pherecydes-Pharma-bmsystems-spin-off-Phase-I-II-Clinical-Trial-EN-VF-150909Pherecydes-Pharma-bmsystems-spin-off-Phase-I-II-Clinical-Trial-EN-VF-150909
Pherecydes-Pharma-bmsystems-spin-off-Phase-I-II-Clinical-Trial-EN-VF-150909
Manuel GEA - Bio-Modeling Systems
 
Harnessing-system-level-modelling-to-effectively-alleviate-the-needs-for-anim...
Harnessing-system-level-modelling-to-effectively-alleviate-the-needs-for-anim...Harnessing-system-level-modelling-to-effectively-alleviate-the-needs-for-anim...
Harnessing-system-level-modelling-to-effectively-alleviate-the-needs-for-anim...
Manuel GEA - Bio-Modeling Systems
 

Plus de Manuel GEA - Bio-Modeling Systems (13)

plaquette-Adebiotech-fevrier-2016
plaquette-Adebiotech-fevrier-2016plaquette-Adebiotech-fevrier-2016
plaquette-Adebiotech-fevrier-2016
 
Pherecydes-Pharma-bmsystems-spin-off-Phase-I-II-Clinical-Trial-EN-VF-150909
Pherecydes-Pharma-bmsystems-spin-off-Phase-I-II-Clinical-Trial-EN-VF-150909Pherecydes-Pharma-bmsystems-spin-off-Phase-I-II-Clinical-Trial-EN-VF-150909
Pherecydes-Pharma-bmsystems-spin-off-Phase-I-II-Clinical-Trial-EN-VF-150909
 
Harnessing-system-level-modelling-to-effectively-alleviate-the-needs-for-anim...
Harnessing-system-level-modelling-to-effectively-alleviate-the-needs-for-anim...Harnessing-system-level-modelling-to-effectively-alleviate-the-needs-for-anim...
Harnessing-system-level-modelling-to-effectively-alleviate-the-needs-for-anim...
 
Psychiatric Systems Medicine Pharmaco Psychiatry Creutzfeldt Jakob Cns Neurod...
Psychiatric Systems Medicine Pharmaco Psychiatry Creutzfeldt Jakob Cns Neurod...Psychiatric Systems Medicine Pharmaco Psychiatry Creutzfeldt Jakob Cns Neurod...
Psychiatric Systems Medicine Pharmaco Psychiatry Creutzfeldt Jakob Cns Neurod...
 
Bm Systems Scientific Epa Conference Heuristic Mathematic Concepts Synergies ...
Bm Systems Scientific Epa Conference Heuristic Mathematic Concepts Synergies ...Bm Systems Scientific Epa Conference Heuristic Mathematic Concepts Synergies ...
Bm Systems Scientific Epa Conference Heuristic Mathematic Concepts Synergies ...
 
Pherecydes Corpprofile En
Pherecydes Corpprofile EnPherecydes Corpprofile En
Pherecydes Corpprofile En
 
Papier Cadi Canal Muller Med Sci June2009
Papier Cadi Canal Muller Med Sci June2009Papier Cadi Canal Muller Med Sci June2009
Papier Cadi Canal Muller Med Sci June2009
 
Eec Systems Medicine Workshop Report En
Eec Systems Medicine Workshop Report EnEec Systems Medicine Workshop Report En
Eec Systems Medicine Workshop Report En
 
Pherecydes Pharma Bmsystems Biodefense Publication
Pherecydes Pharma Bmsystems Biodefense PublicationPherecydes Pharma Bmsystems Biodefense Publication
Pherecydes Pharma Bmsystems Biodefense Publication
 
Pharmacopsychiatry Bmsystems Max Planck Publication Biomarkers Cns
Pharmacopsychiatry Bmsystems Max Planck Publication Biomarkers CnsPharmacopsychiatry Bmsystems Max Planck Publication Biomarkers Cns
Pharmacopsychiatry Bmsystems Max Planck Publication Biomarkers Cns
 
Bm Systems Disruptive Innovation E Conference 20052010 Manuel Gea
Bm Systems Disruptive Innovation E Conference 20052010 Manuel GeaBm Systems Disruptive Innovation E Conference 20052010 Manuel Gea
Bm Systems Disruptive Innovation E Conference 20052010 Manuel Gea
 
Final Agenda Workshop Dg Research Ec Sys Med
Final Agenda Workshop Dg Research Ec Sys MedFinal Agenda Workshop Dg Research Ec Sys Med
Final Agenda Workshop Dg Research Ec Sys Med
 
Bm Systems Presentation Short 30112009
Bm Systems Presentation Short 30112009Bm Systems Presentation Short 30112009
Bm Systems Presentation Short 30112009
 

160302 Partnership Adebiotech ALA_EN final

  • 1. Andrew Lloyd & Associates joins forces with Adebiotech to foster cross-discipline innovation in biotech industries ALA will help raise Adebiotech’s profile and support the independent think-tank in its growth Paris, France, March 2, 2016 – Andrew Lloyd & Associates (ALA), an international public relations group for companies and organizations working in life sciences and innovative technologies, and Adebiotech, an independent cross-disciplinary think-tank for biotechnology in France, today announce that they have signed a partnership agreement to promote interdisciplinary discussion and innovation in the field of biotechnology. In particular, this partnership aims to raise awareness of Adebiotech’s activities amongst specialist audiences interested in developments concerning human and animal health, the environment, energy, food processing, cosmetics, processes and industrial systems, amongst others. Founded in 2006 and boasting 2,000 members and supporters, Adebiotech leads working groups that result in national scientific conferences in emerging areas with strong societal implications. The organization’s activities include connecting public and private bodies with national and regional institutions, and representatives of civil society. The next event will address the issue of antibiotic resistance (An integrated approach, from the environment to mankind – webpage in French). Sponsored by the French Ministry of Social Affairs and Health, the event will play host to all the main players in the field, who will be addressed by 40 speakers on March 16 and 17 at the Biocitech city complex for healthcare and biotechnology businesses in Romainville, France. ALA will support and advise Adebiotech on its public relations activities throughout the year, with the aim of raising the organization’s profile and increasing the visibility of its activities and partnerships, as well as its events. In return, ALA will have opportunities to engage with Adebiotech’s network and its members. “We have chosen to join forces with Andrew Lloyd & Associates, which has a wealth of specialist public relations experience, to support the development of Adebiotech’s reputation and allow us to take part in the cross-disciplinary public debate on biotechnology. Biotech is pervasive to all sectors and represents a major source of jobs and opportunities for growth,” said Manuel Gea, chairman of Adebiotech. “In the immediate future, this strategic partnership with ALA allows us to raise awareness among key media about our work and conference achievements. It will also have long-term benefits for the organization and all our members, allowing us to position ourselves as the leading player at the forefront of the scientific, business and social debates within biotechnology.” “We are delighted to have established this agreement with Adebiotech that focuses on key areas right at the core of our expertise,” said Juliette dos Santos, director at Andrew Lloyd & Associates. “Since our company was founded in 1987, we have specialized in innovative technologies and are involved in all the areas that Adebiotech covers at its conferences, from environment to energy via health care. As such, we are well placed to support the organization by increasing its visibility with its target audience, both in the media and via social networks.”
  • 2. About Adebiotech With France’s largest cross-disciplinary network in the life sciences, Adebiotech promotes dialog between industry – SMEs and large corporations – and academia in the field of biotechnology. Its mandate is diverse: · Promote and support responsible innovation · Break down barriers between disciplines and fields of application · Support existing industrial processes, create new ones and foster their development · Contribute to the dialog between private and public players · Eliminate scientific, technological, regulatory and ethical constraints Adebiotech works across all the fields of application for biotechnology, covering human and animal health, the environment, energy, food processing, cosmetics, processes and industrial systems and creating unprecedented synergies that are required for meeting the challenges of innovation. Founded in 2006, Adebiotech now has 2,000 members and supporters. It enjoys support for its work from ministerial and local authority representatives. http://www.adebiotech.org About Andrew Lloyd & Associates Founded in 1987, Andrew Lloyd & Associates (ALA) is an international public relations consulting group for leading edge companies and organizations involved in emerging technologies. ALA has offices in the United Kingdom and France with multicultural, multilingual staff working closely with partner companies throughout Europe and the US. It is active in technical, business, financial and scientific communications. Specialized in biotechnology, pharmaceuticals, electronics hardware, IT and photonics, ALA provides strategic communication and caters to the full range of public relations requirements for clients ranging from start-ups to major corporations, including institutions, events, organizations and technology clusters. ALA offers strategic positioning, international media relations, influencers and analyst contact management, communication audits, community management, and produces content for marketing collateral. http://www.ala.com Media contact and analysts Andrew Lloyd and Associates Lise Beltzung – Juliette Dos Santos lise@ala.com / juliette@ala.com Tel: +33 1 56 54 07 00 @ALA_Group